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The role of serotonin in human brain function remains elusive due, at least in part, to 
our inability to measure rapidly the local concentration of this neurotransmitter. We 
used fast-scan cyclic voltammetry to infer serotonergic signaling from the striatum of 
fourteen brains of human patients with Parkinson’s disease. Here we report these novel 
measurements and show that they correlate with outcomes and decisions in a 
sequential investment game. We find that serotonergic concentrations transiently 
increase as a whole following negative reward prediction errors, while reversing when 
counterfactual losses predominate. This provides initial evidence that the serotonergic 
system acts as an opponent to dopamine signaling, as anticipated by theoretical models. 
Serotonin transients on one trial were also associated with actions on the next trial in a 
manner that correlated with decreased exposure to poor outcomes. Thus, the 
fluctuations observed for serotonin appear to correlate with the inhibition of over-
reactions and promote persistence of ongoing strategies in the face of short-term 
environmental changes. Together these findings elucidate a role for serotonin in the 
striatum, suggesting it encodes a protective action strategy that mitigates risk and 





The neurotransmitter serotonin influences a broad range of brain functions, including 
mood, sleep, learning, and decision-making (Portas, Bjorvatn et al. 2000, Must, Juhász et 
al. 2007, Diekhof, Falkai et al. 2008), and is thus implicated in a diverse range of 
diseases, including obsessive compulsive disorder (Hu, Lipsky et al. 2006), anorexia 
nervosa (Kaye, Gendall et al. 1998) and depression (Whittington, Kendall et al. 2004, 
Risch, Herrell et al. 2009). However, there is much debate as to what it actually encodes. 
Various data and arguments favor aspects of it as being opponent to dopamine, thus 
suggesting a role in punishment and loss (Deakin 1983, Graeff and Deakin 1991, Daw, 
Kakade et al. 2002, Cools, Roberts et al. 2008, Crockett, Clark et al. 2009, Tanaka, 
Shishida et al. 2009, Boureau and Dayan 2011). Other evidence suggests a role in 
patience while waiting for a reward  (Miyazaki, Miyazaki et al. 2012, Worbe, Savulich et 
al. 2014, Fonseca, Murakami et al. 2015, Li, Zhong et al. 2016), disengagement (Tops, 
Russo et al. 2009), motor activity (Jacobs 1994), or even reward (Dölen, Darvishzadeh et 
al. 2013, Liu, Zhou et al. 2014, Li, Zhong et al. 2016). Recent optogenetically tagged 
recordings from serotonergic neurons in the raphé have not resolved these debates 
(Cohen, Amoroso et al. 2015), perhaps partly because of heterogeneity among 
serotonin neurons (Lowry 2002). A voltammetric approach in awake, behaving, humans 
may offer new insights into the role of serotonin at a temporal resolution that reveals 
dynamic events several orders of magnitude faster than positron emission tomography 
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(Yao, Li et al. 2009) whilst also observing concentrations of the neurotransmitter at 
downstream structures directly, rather than assuming linearity with firing rates in the 
raphé (Montague, McClure et al. 2004).  
 
Recently, we developed a  fast-scan cyclic voltammetry procedure to identify dopamine 
fluctuations in patients with Parkinson’s disease who were undergoing surgery for deep 
brain stimulator implantation (Kishida, Saez et al. 2016). These unique multi-subject 
recordings provided millisecond-resolved estimates of relative fluctuations in the 
concentration of this neurotransmitter whilst patients played an investment task that 
was designed to elicit adaptive behaviour in the face of rewards and punishments.  
Serotonin also produces redox reactions around this range; thus, were it possible to 
distinguish serotonin from dopamine, we could measure relative serotonergic responses 
from exactly these same signals, thus addressing its involvement in the same task.  
There are approaches to perform this separation or boost serotonin signals in slices or in 
vivo in other animals such as picking peaks in the voltammetric recordings visually (John 
and Jones 2007), using drugs (John and Jones 2007, Hashemi, Dankoski et al. 2011) or 
even optogenetics (Xiao, Privman et al. 2014). However, these do not readily extend to 
studies in humans.  
 
Here we derived a principled supervised learning method to apply to these same human 
recordings to measure trial-by-trial fluctuations in extracellular concentrations of 
serotonin, distinguished from dopamine. We used this to measure serotonin transients 
in 16 hemispheres from patients as they performed the investment task (12 of these 
recordings were used in the previous dopamine assessment). In the task, patients 
selected an investment level on each trial as market prices unfolded according to real 
historical financial markets (Lohrenz, McCabe et al. 2007). Dopamine transients in this 
task were found to encode not the typical ‘reward prediction error’ but rather a signal 
that combined actual and counterfactual reward prediction errors (the latter when 
subjects invested little, and so experienced regret or rejoicing when the market rose or 
fell respectively) (Kishida, Saez et al. 2016). We hypothesized that serotonin may 
function in a similar way but in the loss domain, with the potential to represent 
counterfactual losses from foregone gains akin to a regret signal (a positive reward 
prediction error when investments are low). Moreover, given the theorized role of 
serotonin in active avoidance (Dayan and Huys 2008), we investigated whether 
fluctuations in serotonin correlated with avoidance behavior in the task (i.e. reducing 
one’s level of exposure) to actual or counterfactual losses. 
 
 
d. Materials and Methods 
 
 
Participants & Fast-scan cyclic voltammetry  
Fourteen patients (aged 61.1 ± 9.7 yrs., 2 female) undergoing surgery for the 
implantation of deep brain stimulation (DBS) electrodes participated in the experiment. 
©    2018 Macmillan Publishers Limited. All rights reserved.
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Two patients participated on separate days during right and left implantation to give a 
total of n = 16 recordings. All patients had a diagnosis of Parkinson’s disease. 
Participants provided informed consent and were instructed that they could opt out of 
the experiment at any time. Procedures were approved by the Virginia Tech and Wake 
Forest Baptist Medical Center Institutional Review Boards (IRB #11-078). No adverse 
effect of the extended surgical procedure was reported. Eleven of our participants (12 
hemispheres) formed part of the cohort reported in (Kishida, Saez et al. 2016). In 
Supplementary Table 1 we provide details of disease duration, medication and 
comorbidities. During the surgery and during our test period, all patients were off their 
dopamine-related medications but remained on all other pharmacological treatments. 
For details of the surgical and voltammetry procedure see Supplementary Materials and 
Methods. Our voltammetric electrochemical assays relied upon redox reactions of 
serotonin along a carbon fiber (at 10 Hz), which we assumed would produce measurable 
current changes in proportion to the concentration of the chemical species in the 
extracellular space (for full details of the carbon fiber and FSCV protocol see 





Participants played a decision making game in a simulated ‘stock market’. Participants 
were first endowed with 100 points, and, on each trial they had to decide an amount to 
invest in the stock market. This amount could be 0%, 10%, 20%, 30%, 40%, 50%, 60%, 
70%, 80%, 90% or 100% of their points. At the beginning of a game with a single market, 
participants were first shown a trajectory of previous market moves indicating changes 
in the value of the market (Figure 3A). They were then asked to make their first 
investment decision (submit bet) and following a delay (840 ± 12 msec), the market 
value change was revealed and players lost or gained points in accordance with market 
returns. Following this outcome, participants then submitted a further 19 investment or 
‘bet’ decisions in a self-timed manner. On average, players waited 4.5 secs to submit 
their next decision after the reveal event. In all 6 markets of 20 decisions were played. 
Our markets were consistent with real historical markets (e.g. mimicking events before 
and after 1929 Wall St. crash and 1987’s ‘black Monday’).   
We chose this decision-making task since it is engaging and it could be used to 
interrogate the serotonergic response to ’what is’ as well as ’what could have been’. The 
latter involve so-called counterfactual or fictive reward prediction errors (RPEs). These 
errors are ecologically important as learning signals and have been previously shown to 
activate the human striatum (Lohrenz, McCabe et al. 2007). For the details of how we 
computed reward prediction error on each trial see Supplementary Materials and 
Methods   
 
The game was designed with 6 markets of 20 decisions (120 decisions). In 14 of our 16 
experiments, the participants completed the full game. For two patients, recordings 
©    2018 Macmillan Publishers Limited. All rights reserved.
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were stopped prior to experimental completion with 5 markets (100 decisions) and 2 
markets (40 decisions) completed. Thus a total of 1820 trials were played. From those 
1820 trials, a total of 1729 trials could be associated with prospective actions within a 
market (i.e. where [bet(t+1) - bet(t)] can be computed within a given market). In figure 4 
we present the concentration differences in serotonin for negative compared to positive 
reward prediction errors at high [60 – 100%] and low [0 – 50%] betting levels. Here 1724 
trials are included as 5 trials resulted in RPEs equal to zero.  In figures 5 and 6 we 
examine these 1724 bet decisions parametrically and in terms of the adjustments in bet 
made on the next trial. We show the transients in serotonin associated with lowering, 
holding or raising one’s bet, from investment levels of *0%+, *10%, 20%], [30%, 40%], 




Testing Reward Prediction Errors and Action Control  
For each voltammogram we applied the model’s serotonin coefficients to predict 
concentration levels of serotonin at 100 msec temporal resolution. For each trial we 
collected transient responses of 700 msec duration around the time of market reveal (0 
msec) from -100 to 600 msec. Data were z-scored over an individual market and 
baseline corrected within their cell to zero at either -100 msec (Figure 4) or 0 msec 
(Figures 5  and 6).  
 
To test for responses that corresponded with reward prediction errors (Figure 4), we 
tested the fluctuations in serotonin transients at the time of market reveal (the 
outcome of their decision) from 0 – 600 msec. For this analysis we spilt our trials 
according to the outcome-related reward prediction error and according to the bet size 
(high or low). To test whether these prediction-error related-responses (Figure 4) 
further corresponded with prospective action encoding (Figures 5 & 6) we performed a 
second analysis. Specifically we tested, again, the fluctuations in serotonin transients at 
the time of market reveal from 0 – 600 msec. For this analysis however, we spilt our 
trials according to the outcome-related reward prediction error (negative; Figure 5 and 
positive; Figure 6), and according to the decision to ‘raise’ ‘hold’ or ‘lower’ the current 
bet from levels (0%, [10-20%], [30-40%], [50-60%], [70-80%] , [90-100%]). We aimed to 
examine differences in serotonin transients associated with negative compared to 
positive reward prediction errors. Given our previous findings for dopamine (Figure 2), 
we were also interested in the bet dependence on the prediction error since, for 
example, positive reward prediction errors might be coded as a poor outcome if the bet 
decision on that trial was low. We also aimed to determine whether these transients 
predicted decision making on the next trial – i.e. what adjustment might be applied 
from current investment levels. For full details of the statistical analysis applied to test 
for reward prediction error-related serotonin responses and to test for action control-
related responses please see Supplementary Materials and Methods. 
 








Serotonin Concentrations: Estimation Results 
We followed a supervised-learning approach for extracting serotonin signals (Kishida, 
Saez et al. 2016). We created a training set of voltammograms taken from a set of 
probes constructed identically to those used in the patient recordings. The probes were 
exposed to analytes in a flow cell containing a known range of serotonin concentrations 
(from 0 – 8000 nM) confounded with various concentrations of dopamine and pH levels. 
The concentration dependence of the shape and magnitude of the serotonin redox 
current was directly apparent (Figure 1A). We therefore trained a multivariate penalized 
regression model (Tibshirani 1996) to extract serotonin concentration estimates from all 
points of each trace (1000 samples over 10 msec, Figure 1A). We aimed to produce a 
dual-transmitter model that could predict both serotonin and dopamine, since we had 
previously observed task-related dopamine fluctuations in these samples.  
 
We used L1-penalized regression to create a generalizable dual-transmitter regression 
model that estimated the concentrations of DA independent of the ambient levels of 5-
HT and pH, and 5-HT, independent of the level of DA and pH (Supplemental Information, 
Figure S1). We found that regression coefficients were distributed throughout the trace 
indicating that concentration levels were best predicted by considering not only the 
peaks of oxidation and reduction but also other points distributed across the voltage 
sweep (Figure 1A). Crucially we were able to estimate the concentrations of serotonin in 
each mixture independent of dopamine (Figure 1B) and we could predict dopamine 
concentration levels independent of serotonin (Figure 1C) Moreover, our predictions for 
serotonin were trained to ignore altering pH levels (Supplemental Information, Figure 
S2).   This model estimated the true serotonin levels within 90% confidence intervals of 
the estimated levels in absolute terms (Figure 1D), even in the presence of dopamine 
and at differing pH. We also tested whether at very low concentrations we could 
differentiate 5-HT concentrations and found a resolution of ~100 nM (Supplemental 
Information, Figure S2). 
 
Figure 1A shows that determining the low contamination of the models is difficult to 
observe by visual inspection, since the voltammograms for changing dopamine 
concentrations appear similar to those for serotonin (Figure 1A).   For additional 
validation of our procedure, we compared the dopamine predictions to our previously 
published findings (Figure 2). We confirmed that, on the identical datasets to those 
previously published (17 recordings in total), we could replicate previous results on 
transient fluctuations in dopamine from the dorsal striatum (Kishida, Saez et al. 2016) 
(Figure 2). We also show in a supplemental analysis (Figure S2), the correlation structure 
©    2018 Macmillan Publishers Limited. All rights reserved.
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amongst our DA and 5 HT estimates where small positive correlations were found to 
exist. 
 
Behavior on the Sequential Investment Task 
Figure 3A shows the sequence of events in the investment game (Lohrenz, McCabe et al. 
2007) which participants played during voltammetric recordings from dorsal striatum. 
The game was designed to elicit prediction-, prediction error-, reward- and future 
investment-related signals associated with revelation of market price movements on 
120 separate trials over 6 historical markets (20 moves per market). On each trial 
participants chose a level of investment for their current endowment with possible 
choices from 0-100% with 10% increments (Figure 3A) and submitted their choices. 
Then participants  were shown the market move (its change in value Figure 3A), to end a 
trial. Our behavioral data showed that over all subjects, bets were distributed bimodally 
across these 11 possible investment choices (Figure 3B), with investment levels 
distributed around 50% and also peaking at 100%. Reward prediction errors measure 
the difference between the return on a trial and a prediction. We defined the return as 
the fractional change in wealth (combining the current bet size and market change), and 
the prediction as an average of recent previous returns. We also scaled this difference 
by the standard deviation of those previous returns (see Experimental Procedures). 
Across the cohort, this led to a spectrum of positive and negative reward prediction 
errors (Figure 3C). Further, based on our previous results (Kishida, Saez et al. 2016) we 
considered counterfactual as well as real outcomes depending on the current betting 
level. This study suggested that negative outcomes could be experienced in two ways: 
the first were those outcomes where negative reward prediction errors were 
experienced and so events were ‘worse than expected’ (since bets were high). The 
second were counterfactual negative events, in which positive reward prediction errors 
occurred when bets were low and thus regret on a foregone gain. We correlated the 




Serotonin encodes loss prediction errors 
We assessed serotonin responses in voltammograms at a repetition frequency of 10 Hz 
using the penalized regression models developed above. We examined fluctuations in 
estimated concentrations at the time of trial outcomes (as the market move is revealed) 
and tested for the serotonergic encoding of prediction errors. Figure 4A displays the 
serotonin transients associated with positive and negative reward prediction errors. 
Remarkably, when considering all betting levels, serotonin displayed an upward 
fluctuation to negative prediction errors and a downward fluctuation to positive 
prediction errors (Figure 4A and see also Supplemental Information, Figure S3). Given 
the potential difference in response to negative reward prediction errors at high and 
low betting levels (loss and counterfactual loss/foregone gain respectively), we 
examined serotonin fluctuations across a median split of bet levels. Figure 4B shows 
that this encoding reversed for the lower half of bets with upward serotonin 
©    2018 Macmillan Publishers Limited. All rights reserved.
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fluctuations encoding positive errors and downward fluctuations encoding negative 
errors. The inversion of the encoding can be understood as the presence of a 
counterfactual term for serotonin; which responds to negative outcomes both in the 
context of a surprising loss when one was highly invested in the market and a surprising 
gain when one was not. The difference between Figures 4B and Figure S3 is the baseline 
normalization of the signals to 100ms before revelation of the outcome (Figure 4B) or at 
the time of revelation (Figure S3). We present both as a form of exploratory result. They 
suggest that the dynamics of how the prediction component of the prediction error is 
represented in serotonin concentration would be worth exploring in future studies; in 
particular, higher temporal resolution in the voltammetric signal could elucidate early 
dynamics that alter baseline properties (Schmidt et al. 2013, Figure S3). Here the 
interaction of reward prediction error and bet amount was significant for the earlier 
baseline (Figure 4B). In our Supplemental Information (Figure S3) we also include a 
random effects analysis across patients to ensure that our results are not driven by only 
a few subjects. These additional analyses support our findings when accounting for 
individual differences. 
 
To allow for duration of serotonergic signaling to be altered in response to reward 
prediction errors, we computed the area under the curve to indicate ‘cumulative 
serotonin’ responses. For this analysis the interaction of prediction error (positive or 
negative) and bet invested (high or low) was significant (Figure 4C). In particular, the 
response to positive reward prediction errors seemed to induce a depression in 
serotonin that was more prolonged than in the low bet condition. Further, a parametric 
analysis revealed a small but significant negative correlation between the serotonin 
response and RPE at high bets and a small but significant positive correlation between 
serotonin response and RPE at low bets (Figure 4D). To examine the subjective effects of 
actual and counterfactual gains and losses, rather than to reward prediction error per 
se, we conducted a further supplemental analysis (Figure S4). This revealed a lack of a 
parametric effect in gains or losses (Figure S4). 
  
 
Serotonin protects investors from loss 
Given these bet-dependent prediction error transients, we sought to establish 
serotonin’s influence on investment decisions. The effect of counterfactual outcomes on 
both dopamine (Kishida, Saez et al. 2016) and serotonin (Figure 4) suggests that it is 
crucial to perform the analysis of action encoding (betting more or less) at different bet 
levels since a bet of 0% could result in large foregone gains (i.e., counterfactual losses), 
while a bet of 100% could result in large actual losses. In other words, in the context of 
this task, one’s next move carries two distinct risks of loss on the upcoming trial. We 
tested whether fluctuations in 5-HT could be used to predict the bet level on the next 
trial. Using a multiple linear regression we tested for serotonin and game factors in 
predicting the next decision. Specifically, our independent variables included the area 
under the curve of the 5-HT transient from 100 – 600 msec, the bet level, the polarity of 
the RPE at trial (t), as well as their interactions. Our dependent variable was the change 
©    2018 Macmillan Publishers Limited. All rights reserved.
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in bet at trial (t+1). Our regression model revealed significant predictive power in 
upcoming decision (F-statistic vs. constant model: 32.4, p-value < 0.00001, 
Supplementary Table 2). Importantly the regressor describing the interaction of 
serotonin and current bet level was a significant predictor of the upcoming decision (p = 
0.04). This was a negative interaction indicting that for large serotonin responses and 
large bets, participants tended to decrease their bet and for large serotonin responses 
and small current bets, participants tended to increase their bets. We found a that the 
three-way interaction of serotonin, bet level and RPE sign was at trend level significance 
(p = 0.13), Supplementary Table 2. 
 
To examine and illustrate these regression effects, we first separated out ranges of 
current bet levels (Figure 5A), and examined how serotonin transients were associated 
with decisions following a negative reward prediction error (Figure 5). We tested the 
relationship between serotonin responses and current bet levels at trial (t) for decisions 
to ‘lower’ and for decisions to ‘hold or raise’ the bet on trial (t+1) (Figure 5B). These 
analyses are a recapitulation of the negative RPE responses in Figure 4 but separated 
according to what the subject decides to do next. We found that under the conditions of 
the decision to withdraw from the market following negative reward prediction errors 
there was a strong positive correlation between 5-HT and current betting levels (Figure 
5C). This is important given that withdrawal from the market (i.e. lowering one’s bet) is 
consistent with the hypothesized role for serotonin in forms of avoidance (Dayan and 
Huys 2008). This striking parametric effect is indicated in the serotonin time courses of 
figure 5B. We can see that reducing the bet from a high amount implies reducing the 
risk of actual loss, and is associated with positive serotonin fluctuations (Figures 5B). 
Reducing the bet from an already low amount implies increasing the risk of 
counterfactual losses, and is associated with negative fluctuations. A trend towards a 
significant positive correlation for serotonin and decisions to hold-or-raise one bets was 
also observed. In the time-courses we can see that particularly at 10-20% bet levels, 
serotonin rises following a negative RPE and is associated with a subsequent raise-or-
hold bet decision. This direction is again consistent with serotonin protecting against 
counterfactual losses on the next trial.   
 
In figure 6 we explore the same dependencies but following positive reward prediction 
errors. Here at low bets, again from 10-20% levels we observe a upgoing serotonin 
transient (Figure 6B) that dominates the low bet regime (Figure 4B). At this betting level 
both ‘lower’ and ‘raise-hold’ decisions are associated with a positive transient. 
Significant negative-going fluctuations are observed at the lowest betting level of 0%. 
No parametric effects are observed for either decision following positive reward 
prediction errors (Figure 6C and D). 
 
In order to investigate the timing of these decision-related transients further, we 
extracted the peak 5-HT response from every trial and tested whether a faster time to 
peak corresponded with decisions from investment on the next trial. For responses to 
negative reward prediction errors we found no timing effects in an analysis of decision x 
©    2018 Macmillan Publishers Limited. All rights reserved.
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bet-level. However, in response to positive reward prediction errors we saw a significant 
effect of time to peak on the decision to lower, hold or raise ones’ bets following the 
outcomes. Specifically, the decision to raise ones’ bets was associated with slower 5-HT 
transient peaks as compared to decisions to hold or reduce current betting levels. No 
effect of bet level or interaction was observed (Supplemental Information Figure S5). 
This may suggest that fast serotonin signals are associated with withdrawal from 





We used a modern statistical method to extract serotonin signals from fast-scan cyclic 
voltammetric data. We showed in vitro using a flow cell that we could extract separate 
5-HT and dopamine signals from a single voltammogram, even at variable pH, and then 
applied our method to recordings taken in vivo from human Parkinson patients playing 
an investment game. We found that at the time that the outcome of a round was 
revealed, serotonin encoded a prediction error for actual reward when subjects were 
substantially invested, and an inverted prediction error for counterfactual reward (i.e., 
regret) when subjects had failed to invest. Moreover, these serotonin concentration 
fluctuations on a trial were positively correlated with protective choices made by 
subjects in the subsequent trial following negative reward prediction errors. 
 
Our findings provide novel evidence that serotonin encodes loss-related prediction 
errors. This finding ratifies and extends previous theoretical accounts which 
hypothesized a role for serotonin in aversive prediction and learning (Deakin 1983, Daw, 
Kakade et al. 2002). For the high bet case, our findings demonstrate the opposite of 
standard accounts of the activity of dopamine neurons (Schultz, Dayan et al. 1997, 
Kishida, Saez et al. 2016) or transient fluctuations of dopamine concentrations (Flagel, 
Clark et al. 2011) recorded in conventional Pavlovian or instrumental paradigms in 
animals other than humans. For the low bet case, our results for serotonin are the 
mirror image of those for dopamine on the same task, showing a sensitivity to 
counterfactual as well as actual outcomes (Kishida, Saez et al. 2016). 
 
Our second major finding was an emergent action code in serotonin that could be used 
to predict the change in bet following negative reward prediction errors. In particular 
our findings related to betting less or holding on the next trial are consistent with 
computational accounts of serotonin in active avoidance (Dayan and Huys 2008, Dayan 
and Huys 2009). However, here too the signaling was not unidirectional. Positive 
fluctuations to lower bets and negative ones to holding predominated when current bet 
levels were high. However, they flipped polarity at 50%, suggesting that serotonin drops 
when avoidance is overall detrimental, and likely to expose the player to foregone gains. 
Colloquially this might be deemed as a signal that both ‘secures in place’ when risk is 
already low and ‘retreats’ from dangerous high-risk investments. The dependencies on 
prior sensory experience and its sensitivity to context (previous bet amounts) may help 
©    2018 Macmillan Publishers Limited. All rights reserved.
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clarify some formerly confusing and seemingly contradictory findings with respect to 
learning signals and reward error processing (Yacubian, Gläscher et al. 2006). (Figures 5B 
& C, 6A).  
 
Recently serotonergic firing in rodents has been associated with patience (Miyazaki, 
Miyazaki et al. 2012). They found that optogenetic stimulation of rodent serotonergic 
neurons in the dorsal raphé enables waiting for delayed reward (Miyazaki, Miyazaki et 
al. 2014). Similarly, fibre photometry recordings from the dorsal raphé nucleus have 
recently demonstrated increased tonic firing of serotonergic neurons during a reward-
related anticipatory period, and phasic firing on reward acquisition (Li, Zhong et al. 
2016). In future work, an experimental manipulation of the time from bet-submission to 
outcome in our task would enable us to formally test the role of serotonin in signaling 
patience for anticipated reward.  With regard the outcome-acquisition related activity 
(Li, Zhong et al. 2016), our results also find increased 5-HT to positive reward prediction 
errors but only in the context of low bets (when outcomes could have been better). 
Studies that systematically vary actual and counterfactual gains and losses might be 
required to unravel these effects in animals.  
 
Our findings are more directly comparable to studies which investigated lose-shift and 
win-stay behaviors. For example, Bari et al (Bari, Theobald et al. 2010) have shown that 
an acute-dose of SSRIs in rodents can increase lose-shift behavior but that longer-term 
chronic administration increased win-stay behaviors. Similar effects on lose-shift 
behaviors in humans have been associated with genetic polymorphisms in the serotonin 
transporter gene (SERT), which was dissociated from dopamine transporter 
polymorphisms on perseveration (den Ouden, Daw et al. 2013) in the same task. We 
show that serotonin estimates from our participants are associated with lose-shift 
behaviours. But interestingly the associated shift behavior is not a simple ‘withdrawal’ 
from the game. Rather, the shift behaviors associated with serotonin increases (Figure 
5B) is towards the centre of our betting levels. These effects are observed following 
negative reward prediction errors and might mean that the player is not exposed to ‘too 
much’ risk while also ensuring that they do not ‘miss out’ on future gains.  
 
Pharmacological manipulations using tryptophan depletion in humans supports this idea 
of behavioral effects of 5-HT in the face of aversive outcomes with reports of both 
Pavlovian and instrumental predictions of negative events reduced following dietary 
depletion (Crockett, Clark et al. 2012), as well as reports of a specific model-based or 
goal-directed deficit (Worbe, Palminteri et al. 2016). Overall, our methodology provides 
a unique opportunity to understand the role of serotonin in the human brain in 
computational terms. Relating these findings to our previous work we provide evidence 
for serotonin’s loss-opponency to dopamine’s gain-dependent signals (Kishida, Saez et 
al. 2016) and further extend this valence dependent activity with evidence for a role in 
subsequent action selection. Our analysis could be further extended to examine, for 
example, individual differences in reward prediction errors or in decision making. This 
may reflect altered model-based goals. Testing such a proposal is beyond the scope of 
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the present work, but would start from developing a quantitative parametrized 
computational account of the full task. For example, the proposed role of serotonin in 
regulating temporal discounting and impulsivity (Doya, 2007) could be explored with a 
temporal difference model of the task (and manipulations of cue-timings for example). 
Our results, at least informally, are consistent with a role for serotonin in controlling 
impulsivity. In particular, following negative reward prediction errors, the impulsive 
choice may be to lower further one’s investment. However, at low bet levels, serotonin 
increases are associated with decisions to ‘hold’ or even ‘raise’ the bet. This may be a 
protective signal that guards against over-reactions to negative outcomes. Further in 
our supplementary analysis (Figure S5), we show that after outcomes that elicit positive 
reward prediction errors, the serotonin transient is faster for lower, or hold decisions, 
perhaps preventing an impulsive raise in betting levels. Our reward-prediction error and 
action encoding transients might also be considered in light of models of risk 
assessment. Risk, typically modelled as predicted outcome variance, has been mapped 
to serotonin function in the basal ganglia (e.g. in Balasubramani et al. 2014). Our 
transient serotonin increases to negative RPEs at high bets and low bets are associated 
with decisions to lower the bet and to hold or raise bets respectively. Thus 5-HT may 
seek a mid-point where the potential variability in both actual and counterfactual losses 
are balanced (e.g. minimizing maximal losses). 
 
Limitations of the current study are related to both the human brains from which the 
signals were acquired and the specificity of voltammteric signal extraction. Our cohort 
comprised 14 patients with Parkinson’s disease. This pathology has been associated 
with aberrations in some decision-making parameters – including impulsivity (Voon, 
Irvine et al. 2014). Though our paradigm did not address learning per se, the effect of 
valence on learning and subsequent decision-making has been shown to be affected by 
dopamine medication. In patients off medication positive outcomes tend to affect 
learning more prominently, while patients off dopamine medication show a greater 
sensitivity to negative outcomes – effects thought to be controlled by a high dopamine 
‘tone’ or ‘floor’ on medication (Frank, Seeberger et al. 2004). Though in the absence of 
learning, a similar off/on study showed that decision making tends to be improved by 
dopamine medications in patients generally (Shiner, Seymour et al. 2012), though here 
the loss domain was not explicitly investigated. Other studies have corroborated (Frank, 
Seeberger et al. 2004) showing reduced sensitivity to negative feedback when patients 
are on medications (Euteneuer, Schaefer et al. 2009). Our task did not require learning. 
In other decision-making studies without learning, it has been shown that patients with 
Parkinson’s disease and age-matched controls perform comparably (unlike Parkinson’s 
patients with dementia, who are not in our cohort) (Delazer, Sinz et al. 2009). Hence, 
the type of game we chose for our participants has been shown to engender near-
normal performance. Nevertheless, the pattern of choice selection may not fully reflect 
the statistics of choice in people without neurological disease. Secondly, patients with 
Parkinson’s disease may exhibit cross-loading of these particular neurotransmitters into 
the alternate axonal terminals. Specifically, levodopa is thought to induce a ‘false-
transmission’ of dopamine via serotonin axons, and may contribute to the dyskinesias 
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associated with long term L-Dopa use (Mathur and Lovinger 2012, Politis, Wu et al. 
2014). This cross loading would reduce the distinct effects of dopamine and serotonin in 
the striatum (Montague, Kishida et al. 2016). These caveats deserve study in their own 
right using this type of protocol. Here we show the feasibility of dissociating dopamine 
from serotonin and thus the procedures may be extended to test particular cross-talk 
hypotheses that might contribute to movement and decision-making impairments. Our 
measurements were restricted to the caudate and putamen – according to each 
patient’s pre-planned surgical trajectory for the eventual placement of the DBS 
electrode (which followed after our recordings had been completed along the same 
guide tube). These regions have been shown to activate in response to real and 
counterfactual reward prediction errors in previous fMRI studies of this task: caudate 
(Lohrenz, McCabe et al. 2007), putamen (Chiu, Lohrenz et al. 2008).  However, we could 
not access the ventral striatum with our probe, where reward prediction errors are 
pronounced (Pagnoni, Zink et al. 2002) and thus cannot rule out a role for 5-HT in 
modulating this or other regions such as the orbitofrontal cortex (Knutson and Cooper 
2005), during this task. Furthermore, our extraction model only accounted for 
dopamine, serotonin and pH changes, but will not account for systematic voltammetric 
changes induced by other neuromodulators or metabolites. For example, serotonnin’s 
metabolite, as 5-hydoxyindole acetic acid (5H-1AA) has been observed at levels higher 
than serotonin in voltammetric recordings in vivo in rodents and with similar oxidation 
and reduction characteristics. Though we cannot directly rule out the role of a 
metabolite, its systematic (and speeded) fluctuation in concert with decision variables 
would still suggest a role for the serotonergic system in reacting to negative outcomes 
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j. Figure Legends 
 
Figure 1. Serotonin concentration prediction from dual transmitter model 
(A) An illustration of voltammograms acquired for varying levels of serotonin 
concentration (left) and dopamine concentration (right) in the flow cell. We see that low 
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to high concentration levels produce changes in current magnitude around the 
oxidation potentials (insets). Concentration is denoted by []. (B) The flow cell predictions 
are illustrated for serotonin under varying concentrations of dopamine in the mixture. 
Serotonin was sampled at each level of concentration from 0.1 - 8µM in 0.1µM 
increments. For each of these 80 concentrations we computed the serotonin prediction 
over different levels of dopamine. Not all concentration mixtures for dopamine and 
serotonin were acquired and acquired mixtures are denoted by the asterisk. Over this 
test grid we interpolated (using linear triangulation) across the acquired tests samples 
to produce a 3-dimensional heat map of serotonin predictions. This plot show that 
serotonin predictions do not vary systematically with increasing dopamine levels. We 
illustrate one outlying serotonin prediction which was observed but not included in the 
interpolated plot for visualization purposes. (C) Flow cell predictions for dopamine in the 
mixture, plotted as a function of increasing dopamine and increasing serotonin as per 
(B). Again, dopamine predictions using our model do not appear to be systematically 
affected by the level of serotonin in the sample. (D) We tested 200 out-of-sample 
voltammograms for each concentration level to quantify the error in generalizability.  
Illustrated in grey are predictions for different concentration ranges and their 99.99% 
confidence intervals. Red crosses denote the mean of the (correct) test range. For each 
range we randomly selected 20 predictions from the full test set. 
 
 
Figure 2. Dopamine replication in mixture model 
We performed an in vivo validation by replicating the previous dopamine findings using 
our new multivariate mixture model. We split trials into low ([0-50%]), medium ([60-
80%]) and high ([90-100%]) bets and examined dopamine transients at these different 
bet levels in response to positive and negative reward prediction errors. As per the 
findings reported previously for a univariate model (Kishida, Saez et al. 2016) dopamine 
estimates from the dual transmitter model predict dopamine encoding of prediction 
errors. Using two-way ANOVAs with factors RPE (negative RPE, positive RPE) and bet 
levels (high, medium, low) we found a significant interaction at 200 msec (p = 0.005), 
300 msec (p = 0.0001), 400 msec (p = 0.0016), 500 msec (p = 0.0079) and 600 msec (p = 
0.02). Post-hoc 2 sample t test results for each bet level and time point are illustrated (* 
p < 0.05, ***p ≤ 0.001). For validation purposes, we report here, those measurements 
from the original cohort of 17 patients reported in  (Kishida, Saez et al. 2016). Data were 
baseline corrected to zero at 0 msec, and bar graphs depict the mean and s.e.m.   
 
 
Figure 3. Investment game and distributions of bets and RPEs over trials 
(A) In this figure we provide an illustration of the overall task design. To investigate the 
role of serotonin we used an investment game (Lohrenz, McCabe et al. 2007) where 
participants were endowed with an initial 100 ‘points’ and were instructed to invest a 
percentage of this amount for investment into a stock market (historic markets, e.g. the 
1929 Wall St. crash). Participants could choose to invest 0 – 100% (color bar) in 10% 
©    2018 Macmillan Publishers Limited. All rights reserved.
 20 
increments (blue arrow, Bet(t)). On each trial participants submitted their investment 
(upper panel) and 840 msec later (±12 msec std.) were shown the market return (middle 
panel). On the outcome, participants either lost or gained in accordance with their 
investment. From these market moves we calculated the reward prediction error on 
that trial. Following this outcome, participants submitted their next investment (blue 
arrow, Bet(t+1)) at their own pace (lower panel). (B) Distribution of investment choices 
over all participants. (C) Distribution of reward prediction errors, calculated over each 




Figure 4. Serotonin encodes negative reward prediction errors at high bets 
(A) Testing across all outcomes and separating according to either a concomitant 
positive or negative reward prediction error, we found that serotonin fluctuated 
significantly more positively for negative (black line) compared to positive (cyan line) 
reward prediction errors. Six 2-sample t tests were performed over temporal bins [100 – 
600 msec] comparing concentration levels; significant effects of RPE were observed at 
300 and 400 msec (*p < 0.05). Here we baseline corrected at -100msec. (B) Two-way 
analyses of variance of serotonin’s transient response at presentation of the outcome or 
market move were performed for six temporal bins [100-600 msec], with factors reward 
prediction error polarity; positive and negative and bet level; low (0 – 50%), and high (60 
– 100%). These revealed a significant interaction of reward prediction error and bet 
level at 100 msec (F = 14.34, p = 0.0002) and 500 msec (F = 4.89, p = 0.027). Post-hoc 2-
sample t tests were performed using permutation testing to assess within bet-range 
differences in the response to negative compared to positive reward prediction errors. 
For the high bet range (60-100% invested), serotonin transients were significantly 
greater for negative compared to positive reward prediction errors at 100 msec; p = 
0.001, 300 msec; p = 0.011, 400 msec; p = 0.005 and 500 msec; p = 0.01. While for the 
low bet range (0 – 50% invested) responses were significantly greater for positive 
compared to negative reward prediction errors at 100 msec; p = 0.016. Only the 
differential response at 100 msec in the high bet case survived FWE-correction p = 0.005 
(**p ≤ 0.005, *p ≤ 0.05, (**)FWE-corrected).  We also applied one-sample, 2-sided t 
tests in order to investigate the effects of RPE and bet size on 5-HT responses as 
compared to baseline. We find that the difference is driven by significant decreases in 5-
HT following positive reward prediction errors at high bets, and to negative reward 
prediction errors at low bets (<<p<0.005, < p< 0.05).  Bar graphs depict the mean and 
s.e.m. Comparisons of transients with an alternate baseline is presented in 
Supplemental Information figure S3. (C) The area under the curve in B, revealed a 
significant interaction (F = 7.13, p = 0.0077) of RPE and bet level with larger (in time and 
amplitude) negative-going transients for positive reward prediction error responses in 
the high bet condition. (D) We tested the serotonin response at 100msec and its 
correlation with the sign and polarity of the RPE. After omitting 65 outliers (~3% of 
trials) that may drive the effect (outliers defined as RPEs with an absolute magnitude 
greater than 3 and z-scores with an absolute magnitude greater than 5) we see a small 
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but significant correlation for the different bet levels. Serotonin transients are 
negatively correlated with the RPE for high bets (R = -0.0714; p = 0.0113) and positively 
correlated with the RPE for low bets (R =  0.0653; p = 0.0494). To explore these results 
more granularly, we examined individual bins. We found that the only significant 
individual bins were at [20%, 30%], [60%, 70%], and [80%, 90%] with correlation 
coefficients and p-values of (R =  0.19; p = 0.01) , (R =  -0.08; p = 0.06) and (R =  -0.14; p = 
0.009) respectively. This suggests that a putative ‘indifference point’ for counterfactual 




Figure 5. Serotonin and active avoidance following negative reward prediction errors 
(A) Depiction of ‘next actions’. Responses to trial (t) were analysed for bet(t) = {0%, [10-
20%], [30-40%], [50-60%], [70-80%] and [90-100%]}. For each of these six levels we 
examined ‘lower bet’ next actions (black arrows) and ‘hold-or-raise’ bet next actions 
(grey arrows). (B) The n=842 negative RPE transients presented in Figure 4A and 4B are 
represented here but separated according to next-bet decision and current betting 
level. These results are provided in order to explore the significant negative interaction 
between serotonin and current bet on predicting change in bet (Supplementary Table 
2). Consistent with this negative interaction in the regression analysis, we observe that 
large positive 5-HT transients at large bets predict a lowering of the bet at trial t+1 
(black line, right panels). While dips in 5-HT are associated with reducing one’s bet at 
low bet levels to even lower levels (black line, left panels). The opposite effect is 
observed for holding or raising one bets, grey lines (with 0% not showing any significant 
transient effects). Significance here is indicated for uncorrected t tests against zero 
(*p<0.05, **p<0.01, ***p<0.005). (C) Applying a correlation analyses to examine the 
relationship between serotonin and current bet levels when the next decision is to 
lower one’s bet.  We find that over all ‘lower bet’ decisions, serotonin and the current 
bet level were positively correlated (R = 0.3; p < 0.00001).  This indicates that market 
withdrawal is affected by serotonin following poor outcomes. More specifically it 
indicates that serotonin may prevent further withdrawal (when investment is already 
low) and promote withdrawal (when investment is high). (D) Correlating decisions to 




Figure 6. Serotonin and active avoidance following positive reward prediction errors  
(A) Depiction of ‘next actions’ as per negative RPE analysis in Figure 5. (B) Serotonin 
transients (n=882) following positive reward prediction errors as per figure 4A and 4B 
but shown here separated according to decision on next trial and current bet level 
(lower bet on trial (t+1): cyan line, hold or raise bet on trial (t+1): dark green line). Only 
at low bets (where counterfactual losses dominate) did we observe large transients – 
the direction of the transient was not discriminative however in terms of next-bet 
decision. (C) Unlike following negative RPES, no parametric effect, in terms of current 
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bet level and serotonin response, was observed for the decision to lower bet following 
positive reward prediction errors. (D) Similarly, no parametric effects were observed for 
serotonin responses preceding a decision to raise or increase bet levels (following a 
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